# SYCAMORE Study 👉🏼WHAT IS Adalimumab plus Methotrexate for JIA Uveitis 👉🏼CONCLUSION * ADA group was less likely than the placebo group to have treatment failure * a significantly greater proportion of patients in the adalimumab group than in the placebo group could eliminate or reduce topical corticosteroids. * the rate & number of adverse events per patient- year was higher in the ADA group than in the placebo group